Veriti Management LLC lifted its position in shares of Aflac Incorporated (NYSE:AFL – Get Rating) by 8.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,331 shares of the financial services provider’s stock after purchasing an additional 1,368 shares during the period. Veriti Management LLC’s holdings in Aflac were worth $1,116,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of Aflac in the fourth quarter valued at approximately $271,422,000. Renaissance Technologies LLC bought a new stake in shares of Aflac in the fourth quarter valued at approximately $26,468,000. State Street Corp raised its position in shares of Aflac by 1.1% in the fourth quarter. State Street Corp now owns 33,531,471 shares of the financial services provider’s stock valued at $1,957,903,000 after purchasing an additional 379,178 shares during the period. Guinness Asset Management LTD raised its position in shares of Aflac by 32.6% in the fourth quarter. Guinness Asset Management LTD now owns 1,501,640 shares of the financial services provider’s stock valued at $87,682,000 after purchasing an additional 369,258 shares during the period. Finally, Rafferty Asset Management LLC bought a new stake in shares of Aflac in the fourth quarter valued at approximately $20,145,000. 66.45% of the stock is currently owned by institutional investors.
In other Aflac news, Director Toshihiko Fukuzawa sold 1,300 shares of the company’s stock in a transaction on Friday, March 25th. The shares were sold at an average price of $65.50, for a total value of $85,150.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Karole Lloyd bought 1,000 shares of Aflac stock in a transaction dated Thursday, April 28th. The stock was acquired at an average cost of $59.36 per share, for a total transaction of $59,360.00. Following the completion of the transaction, the director now directly owns 38,588 shares in the company, valued at $2,290,583.68. The disclosure for this purchase can be found here. Insiders sold a total of 3,287 shares of company stock valued at $214,350 over the last 90 days. Company insiders own 1.10% of the company’s stock.
Shares of AFL opened at $53.96 on Thursday. The firm has a market cap of $34.76 billion, a price-to-earnings ratio of 8.86, a PEG ratio of 2.01 and a beta of 0.96. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.06 and a current ratio of 0.06. Aflac Incorporated has a fifty-two week low of $51.28 and a fifty-two week high of $67.20. The firm has a 50 day moving average price of $58.46 and a 200-day moving average price of $60.60.
Aflac (NYSE:AFL – Get Rating) last posted its quarterly earnings results on Wednesday, April 27th. The financial services provider reported $1.42 EPS for the quarter, beating analysts’ consensus estimates of $1.38 by $0.04. Aflac had a net margin of 18.90% and a return on equity of 11.96%. The company had revenue of $5.27 billion during the quarter, compared to analyst estimates of $5.16 billion. During the same period in the prior year, the business posted $1.53 EPS. As a group, equities research analysts predict that Aflac Incorporated will post 5.28 earnings per share for the current year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, June 1st. Investors of record on Wednesday, May 18th were issued a dividend of $0.40 per share. The ex-dividend date was Tuesday, May 17th. This represents a $1.60 dividend on an annualized basis and a yield of 2.97%. Aflac’s dividend payout ratio is currently 26.27%.
About Aflac (Get Rating)
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
- Get a free copy of the StockNews.com research report on Aflac (AFL)
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Victoria’s Secret Stock is Out of the Box
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Want More Great Investing Ideas?
- Bear Market Game Plan!
- The 10 Best Stocks to Own in 2022
- 7 Stocks to Buy and Hold Forever
- 3 Stocks to DOUBLE This Year
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.